Maersk-Moller Kimberly's Form 4 filing
Mimedx Group, Inc. (MDXG) · filed Mar 5, 2025
- Accession no.
- 0001376339-25-000025
- Filed
- Mar 5, 2025
- Trade date
- Feb 28-Mar 3, 2025
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $17.8K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maersk-Moller KimberlyCIK 0002029167 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common Stock | SSaleDisposed | −2,111 | $8.41 | −$17,753.51 | 265,271 | Direct | |
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +45,929 | $0.00 | $0 | 314,942 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +36,486 | $0.00 | $0 | 75,794 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.